Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biogen Idec reports death of patient on its MS pill
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Information for healthcare professionals: Rituximab
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
8th International Congress on Autoimmunity
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Multiple sclerosis: association with HL-A3.
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.

Pages